The nation of Zimbabwe has rejected a significant US healthcare agreement worth $367m (272 million pounds) spanning five years because of Washington's insistence on confidential information.
This rejection came to light following a official document from December was disclosed, which showed President Emmerson Mnangagwa felt the deal was "skewed".
An official spokesperson has since clarified that the United States was seeking biological samples for research and profit but refused to share the benefits from future vaccines.
"We will now turn to the difficult and regrettable process of winding down our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had provided more than $1.9bn in health funding to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged more dialogue to find a agreement agreeable to all parties so the nation's vital HIV programme can continue.
Broader Background
This development comes after a similar case in neighbouring Kenya, where a court suspended a similar deal with the US following concerns were raised about the security of citizens' medical information.
After resuming the presidency last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed aid for the US government, but Trump claimed its spending was "wasteful" and his government was pursuing government-to-government agreements to boost openness and accountability.
According to statements, Sixteen African countries have to date signed these new health pacts, constituting over $18.3bn of fresh investment.
Details of the Declined Deal
The money for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy via US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data over an extended period, without any equivalent promise of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," Mangwana explained.
"Effectively, our country would supply the basic resources for medical research without any certainty that the end products would be available to our people if a future pandemic emerge."
National Interest and International Frameworks
He also noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting frameworks previously established via the global health agency.
Mangwana cited its Pandemic Benefit-Sharing scheme created to manage future pandemics.
"This system is intended to ensure that when a country contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how future co-operation might be structured in a manner that honours the sovereignty and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but suggested that talks should continue since a large portion of the nation's Aids initiatives were funded by external financing.
"If technical issues arise, including those involving data governance or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group commented.
The situation emphasises the continuing tensions between receiving crucial international aid and safeguarding national sovereignty in an increasingly interconnected world.